We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
When a material is waste, is a by-product or meets ‘end of waste’ status.
This guidance outlines the circumstances under which a marine licence may be required from the MMO.
Licence and registration application information for companies that deal in precursor chemicals.
This guidance outlines the circumstances under which a marine licence may be required from the Marine Management Organisation.
Guidance for alcohol and drug treatment services to help them get the balance right between providing remote and in-person interventions for service users.
How companies or individuals based in Great Britain should share data and information on the same chemical substance and jointly submit that information to the ‘Comply with UK REACH’ service.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Manual for healthcare practitioners on building and carrying out an effective plan for recovery from substance addiction.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Briefing for drug and alcohol commissioners and providers about men who have sex with men (MSM) who use drugs before or during sexual activity (chemsex).
Guidance on the European Union regulation on explosives precursors, including licensing, labelling and reporting suspicious activity
How the MHRA makes decisions on what is a medicinal product (borderline products).
Customer declaration of specific uses of the scheduled category 1 or 2 substances (multiple transactions).
How to use evidence of drug-related activity and harm to improve prevention and treatment of substance misuse and associated problems.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.